Navega Therapeutics

About Us

Founded in 2018, Navega Therapeutics Inc. is a preclinical stage company pursuing a radically different approach to treat chronic pain and tackle the opioid epidemic. Our epigenetic gene therapy platform has the advantage of being highly specific and long-lasting, which has not been achieved by small molecules thus far. Our pipeline includes different targets for pain relief and ophthalmologic diseases to improve the quality of life of millions of patients.